Chun Wu

  • 5430 Citations
  • 28 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Research Expertise:
Computer-aided Drug Design | Molecular Dynamics Simulation | Molecular Modeling

The long-term goal of my research program is to gain mechanic insights into the structure, dynamics and function of pharmacologically important biomolecules. The insights enable rational drug design using a hierarchical virtual screening protocol including docking, molecular dynamics simulation, and free energy perturbation methods. My current research aims to: 1) develop novel cancer drugs that target DNA/RNA-quadruples, transporter (ABCB1) and kinase (MLK); 2) develop novel analgesic and anti-drug-addiction agents that target G-protein coupled receptors (GPCR) (Dopamine, TAAR1, Opioid) membrane receptors; 3) develop novel anti-virus drugs against herpes virus entry (gD); 4) develop diabetes drug that simultaneously targets inflammation (PPAR).

Honors and Awards:
2010, Travel Award, the IBBI (Isolated Biomolecules and Biomolecular Interactions) conference, Berlin, Germany

2004, Named to the Dean’s list in recognition of Scholastic Excellence, University of Delaware

1999, Excellent Thesis, Xiamen University

Member of:
American Chemical Society (www.acs.org)

Education/Academic qualification

Doctor of Philosophy, doctorate, University of Delaware

Fingerprint Dive into the research topics where Chun Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 5430 Citations
  • 28 h-Index
  • 59 Article
  • 1 Comment/debate
  • 1 Review article

Analysis of vismodegib resistance in D473G and W535L mutants of SMO receptor and design of novel drug derivatives using molecular dynamics simulations

Liao, S., Floyd, C., Verratti, N., Leung, L. & Wu, C., Mar 1 2020, In : Life Sciences. 244, 117302.

Research output: Contribution to journalArticle

  • 3D-QSAR, molecular docking, and dynamics simulation of quinazoline-phosphoramidate mustard conjugates as EGFR inhibitor

    Ruslin, R., Amelia, R., Yamin, Y., Megantara, S., Wu, C. & Arba, M., Jan 1 2019, In : Journal of Applied Pharmaceutical Science. 9, 1, p. 89-97 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Binding of BRACO19 to a telomeric G-quadruplex DNA probed by all-atom molecular dynamics simulations with explicit solvent

    Machireddy, B., Sullivan, H. J. & Wu, C., Jan 1 2019, In : Molecules. 24, 6, 1010.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Dopamine D4 Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy

    Keck, T. M., Free, R. B., Day, M. M., Brown, S. L., Maddaluna, M. S., Fountain, G., Cooper, C., Fallon, B., Holmes, M., Stang, C. T., Burkhardt, R., Bonifazi, A., Ellenberger, M. P., Newman, A. H., Sibley, D. R., Wu, C. & Boateng, C. A., Apr 11 2019, In : Journal of Medicinal Chemistry. 62, 7, p. 3722-3740 19 p.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations